跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
EZETIMIBE LAPL ezetimibe 10 mg tablet bottle (HDPE bottle with molecular sieve sachet)
Approved
STANDARD
EZETIMIBE LAPL ezetimibe 10 mg tablet bottle (HDPE bottle with molecular sieve sachet)
Lupin Australia Pty Limited
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
97ae9770af8b5bee
Company
Lupin Australia Pty Limited
Type
Standard
Approval Details
Approval Id
97ae9770af8b5bee
Product Name
EZETIMIBE LAPL ezetimibe 10 mg tablet bottle (HDPE bottle with molecular sieve sachet)
Artg Id
246019
Artg Name
EZETIMIBE LAPL ezetimibe 10 mg tablet bottle (HDPE bottle with molecular sieve sachet)
Sponsor
Lupin Australia Pty Limited
Company Detail Path
/organization/lupin-australia-pty-limited
Artg Date
2016-07-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
97ae9770af8b5bee
Type
Standard
Back to TGA Approvals
EZETIMIBE LAPL ezetimibe 10 mg tablet bottle (HDPE bottle with molecular sieve sachet) - TGA Drug Approval Details